Clinical performance of the Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit as compared to other multiplex RT-PCR tests

With COVID-19 vaccination rollouts and relaxation of public health policies, a rebound increase in seasonal flu is likely. COVID-19 and influenza share similar symptoms but are managed differently.

In this workshop, our speakers will provide an introduction into the epidemiology of SARS-CoV-2, influenza A, and influenza B and explain the importance of differentiating them in a single test. We will also discuss the clinical performance of the TaqPath COVID-19, Flu A, Flu B Combo Kit as compared to other multiplex RT-PCR tests.

Learning objectives:

  • Discuss the current epidemiological ecosystem in the United States
  • Evaluate the performance data of the TaqPath COVID-19 Flu A, Flu B Combo Kit against two competitor solutions
  • Assess the approved workflow of a real-time PCR testing solution for COVID 19, influenza A, and influenza B

Speakers:

Lauren Miller

Lauren Miller
Scientist, Clinical Applications/Marketing Support,
Thermo Fisher Scientific


Anami Patel, Ph.D.

Anami Patel, Ph.D.
Chief Science Officer, Poplar Healthcare

(*Indicates a mandatory field)